You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0249: Use of Cabergoline, a Dopamine Agonist, Combined with Medroxyprogesterone Acetate in a Subgroup of Patients with Endometrial Hyper-Plasia and Atypical Endometrial Hyperplasia

Article Text

Article menu
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0249: Use of Cabergoline, a Dopamine Agonist, Combined with Medroxyprogesterone Acetate in a Subgroup of Patients with Endometrial Hyper-Plasia and Atypical Endometrial Hyperplasia

https://doi.org/10.1136/ijgc-00009577-200610001-00249

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.